Utilizing data from The Cancer Genome Atlas of all patients with breast cancer (TCGA-BRCA), we identified a significant association between loss of IRF5 expression and worsened prognosis for patients with breast cancer (BC)2. The gene discussed is IRF5; the disease is breast cancer.